MDC 0.00% $6.60 medlab clinical limited

Ann: Notice of Extraordinary General Meeting / Proxy Form, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 178 Posts.
    lightbulb Created with Sketch. 25
    Trust is a must when investing hard-earned cash into these companies and I've lost confidence and trust.
    What is left to keep the company afloat after the proposed gift to SH ?????
    Royalties What.05c ??? per share. Who Knows after EXPENCES ??? A Leopard doesn't change its spots
    Anyway, Make up your own mind.
    These are my key takeaways from the announcement that made up my mind.
    DYOR

    Independent Expert’s Report
    3.8 DisadvIndependent Expert’s Report
    Shareholders should carefully consider the Independent Expert’s Report prepared for the purposes of ASX Listing
    Rule 10.1. The Independent Expert’s Report comments on the fairness and reasonableness of the transactions
    the subject of this Resolution to the non-associated Shareholders. The Independent Expert has determined the
    transaction the subject of this Resolution is not fair but reasonable

    WTF.... IF IT'S NOT FAIR IT'S NOT FAIR ITS A RIPOFF !!!

    The Directors believe that the following non-exhaustive list of disadvantages, may be relevant
    to a Shareholder’s decision on how to vote on the Disposal:
    (a) Disposal of Company IP – as a result of the Disposal, the Company will be disposing
    of the Company IP which may not be consistent with the investment objectives of
    Shareholders. Although Shareholders will continue to receive royalties post
    completion of the Proposed Restructure Transaction, the royalties are limited in time
    and therefore Shareholders will not be able to benefit from the commercialisation of
    the Company IP long term. The size of the Company’s tangible asset base will be
    reduced significantly as a result of the Proposed Restructure Transaction.
    (b) Sale of Main Undertaking - the consequence of the Disposal is that the Company
    will sell its main undertaking and be required by ASX, within a period of 6 months from
    the date of announcement of the Disposal to identify a new project or opportunity or
    risk being suspended from trading by ASX. The Company will also likely be required
    to re-comply with Chapters 1 and 2 of the Listing Rules before its Shares can be
    reinstated to trading following such suspension. There is also a risk that the Company
    may not be able to locate and acquire other suitable investment opportunities.
    3.9 Future activities and direction on completion of the Proposed Restructure
    Transaction
    If the Proposed Restructure Transaction proceeds to completion, the Company intends to
    continue as a listed company to identify new projects and growth opportunities, that will aim
    to generate value for Shareholders and future investors.
    Any such future acquisition of a new main undertaking will require the Company to re-comply
    with Chapters 1 and 2 of the Listing Rules and further details of any such acquisition will be
    11
    released to the Company’s Shareholders and market generally in accordance with the
    Company’s continuous disclosure obligations under the Listing Rules.
 
watchlist Created with Sketch. Add MDC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.